The inhibition of E2F1 in chronic myeloid leukemia (CML) stem/progenitor cells (SPCs) reduced proliferation of CML SPCs, leading to p53-mediated apoptosis. The gene discussed is E2F1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.